BRIEF published on 12/19/2025 at 12:05, 9 months 30 days ago Biotest AG annonce l'approbation par la FDA du Fesilty™ de Grifols Biotest AG Marché Américain Approbation De La FDA Grifols Thérapie Au Fibrinogène
BRIEF published on 12/19/2025 at 12:05, 9 months 30 days ago Biotest AG Announces FDA Approval of Grifols' Fesilty™ FDA Approval Biotest AG U.S. Market Grifols Fibrinogen Therapy
PRESS RELEASE published on 12/19/2025 at 12:00, 9 months 30 days ago Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) Biotest AG announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) for acute bleeding episodes in patients with fibrinogen deficiency Biotest AG Fibrinogen Grifols US FDA Approval Fesilty
BRIEF published on 11/13/2025 at 10:12, 11 months 5 days ago Biotest obtient l'autorisation de mise sur le marché de Prufibry® en Allemagne Biotest AG Essais Cliniques Marché Allemand Approbation Prufibry® Déficit En Fibrinogène
BRIEF published on 11/13/2025 at 10:12, 11 months 5 days ago Biotest Obtains Approval for Prufibry® in Germany Clinical Trials Biotest AG German Market Prufibry® Approval Fibrinogen Deficiency
PRESS RELEASE published on 11/13/2025 at 10:07, 11 months 5 days ago Biotest obtains approval for new human fibrinogen Prufibry® in Germany Biotest AG obtains approval in Germany for new human fibrinogen Prufibry®, expanding intensive care and coagulation factor portfolio with a life-saving therapy for congenital and acquired fibrinogen deficiency Germany Biotest AG Approval Human Fibrinogen Prufibry
BRIEF published on 11/07/2025 at 15:24, 11 months 11 days ago Biotest AG convoque une assemblée générale extraordinaire à la demande de Grifols Assemblée Générale Extraordinaire Grifols SA Société En Commandite Par Actions Biotest AG Changement De Forme Juridique
BRIEF published on 11/07/2025 at 15:24, 11 months 11 days ago Biotest AG Schedules Extraordinary General Meeting at Grifols' Request Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
PRESS RELEASE published on 11/07/2025 at 15:19, 11 months 11 days ago Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A. Biotest AG convenes an extraordinary general meeting at the request of Grifols S.A. to discuss changing its legal form to a partnership limited by shares (KGaA) on 17 December 2025 Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
BRIEF published on 10/23/2025 at 13:21, 11 months 26 days ago Biotest AG Cancels Extraordinary General Meeting Grifols S.A. Extraordinary General Meeting Legal Form Change Corporate Restructuring Biotest AG News
Published on 10/17/2026 at 03:20, 1 day 20 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 1 day 20 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:30, 2 days ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 2 days ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/18/2026 at 14:05, 9 hours 35 minutes ago UEG launches new Patient Representatives Advisory Board to strengthen patient voice in digestive health
Published on 10/17/2026 at 18:00, 1 day 5 hours ago Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 1 day 10 hours ago Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 1 day 10 hours ago AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 2 days 3 hours ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:54, 2 days 3 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 2 days 4 hours ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 2 days 4 hours ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 2 days 5 hours ago KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026
